A specialized medical team from the Department of Hematology and Oncology successfully treated the first case of a 12-year-old girl with T-cell therapy, who was suffering from acute lymphoblastic leukemia, at Queen Rania Al Abdullah Children's Hospital on Wednesday."The Directorate is always striving to be at the forefront of introducing new and advanced medical techniques. The introduction of new methods for treating blood disorders in both adults and children aims to enhance and develop the medical system to serve all age groups suffering from refractory blood diseases." The Director-General of the Royal Medical Services saidThe Director praised the efforts of the medical team overseeing the procedure, which included specialists from the Hematology and Oncology Department, laboratory physicians, and a distinguished nursing and pharmaceutical team.For his part, the hospital director indicated that the child who received T-cell therapy had been confirmed free of the disease and had entered into full recovery, following tests and a bone marrow biopsy.The child's family expressed their gratitude and appreciation to the Royal Medical Services for the efforts exerted, and for its continuous pursuit of providing a comprehensive and safe therapeutic environment for patients, offering optimal medical care with high skill and efficiency.
A specialized medical team from the Department of Hematology and Oncology successfully treated the first case of a 12-year-old girl with T-cell therapy, who was suffering from acute lymphoblastic leukemia, at Queen Rania Al Abdullah Children's Hospital on Wednesday.
"The Directorate is always striving to be at the forefront of introducing new and advanced medical techniques. The introduction of new methods for treating blood disorders in both adults and children aims to enhance and develop the medical system to serve all age groups suffering from refractory blood diseases." The Director-General of the Royal Medical Services said
The Director praised the efforts of the medical team overseeing the procedure, which included specialists from the Hematology and Oncology Department, laboratory physicians, and a distinguished nursing and pharmaceutical team.
For his part, the hospital director indicated that the child who received T-cell therapy had been confirmed free of the disease and had entered into full recovery, following tests and a bone marrow biopsy.
The child's family expressed their gratitude and appreciation to the Royal Medical Services for the efforts exerted, and for its continuous pursuit of providing a comprehensive and safe therapeutic environment for patients, offering optimal medical care with high skill and efficiency.